- Home
- POAI vs ATCH Comparison
POAI vs ATCH Comparison
Compare POAI & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- ATCH
- Stock Information
- Founded
- POAI 2002
- ATCH 2022
- Country
- POAI United States
- ATCH United States
- Employees
- POAI N/A
- ATCH N/A
- Industry
- POAI Industrial Specialties
- ATCH
- Sector
- POAI Health Care
- ATCH
- Exchange
- POAI Nasdaq
- ATCH Nasdaq
- Market Cap
- POAI 7.8M
- ATCH 9.0M
- IPO Year
- POAI N/A
- ATCH N/A
- Fundamental
- Price
- POAI $14.77
- ATCH $0.39
- Analyst Decision
- POAI Hold
- ATCH
- Analyst Count
- POAI 1
- ATCH 0
- Target Price
- POAI N/A
- ATCH N/A
- AVG Volume (30 Days)
- POAI 230.9K
- ATCH 121.0M
- Earning Date
- POAI 11-11-2025
- ATCH 11-14-2025
- Dividend Yield
- POAI N/A
- ATCH N/A
- EPS Growth
- POAI N/A
- ATCH N/A
- EPS
- POAI N/A
- ATCH 0.14
- Revenue
- POAI $1,664,696.00
- ATCH $10,856,612.00
- Revenue This Year
- POAI $486.27
- ATCH N/A
- Revenue Next Year
- POAI $65.50
- ATCH N/A
- P/E Ratio
- POAI N/A
- ATCH $2.97
- Revenue Growth
- POAI 71.65
- ATCH 171.31
- 52 Week Low
- POAI $8.25
- ATCH $0.14
- 52 Week High
- POAI $45.90
- ATCH $26.94
- Technical
- Relative Strength Index (RSI)
- POAI 78.34
- ATCH 46.19
- Support Level
- POAI $12.15
- ATCH $0.45
- Resistance Level
- POAI $15.15
- ATCH $0.53
- Average True Range (ATR)
- POAI 1.98
- ATCH 0.20
- MACD
- POAI 1.19
- ATCH -0.06
- Stochastic Oscillator
- POAI 45.66
- ATCH 0.82
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.